Alkemi Growth Capital

Alkemi Growth Capital invests across the healthcare lifecycle — from early-stage ventures proving clinical or operational models to expansion and late-stage growth rounds. This flexible mandate allows the firm to follow high-performing companies through multiple capital raises. The stage-agnostic approach is typical of India's healthcare market, where companies often require continued capital support to scale across state and regulatory boundaries.

The firm's public materials indicate coverage across healthcare delivery, diagnostics, medical devices, and digital health platforms. India's healthcare ecosystem is fragmented and underserved, creating opportunities in organized hospital chains, specialized single-specialty clinics, lab networks, and technology-enabled care models. The firm does not publish a public list of excluded sub-sectors, though its pure-play healthcare mandate means it does not invest in non-healthcare verticals.

As a sector-specialist firm, Alkemi Growth Capital likely relies on founder networks, clinician referrals, and relationships with hospital and med-tech entrepreneurs across India's major healthcare hubs — Delhi-NCR, Mumbai, Bangalore, and Hyderabad. Specialist firms in India often source through medical conferences, academic hospital partnerships, and direct outreach to companies navigating India's complex regulatory pathways. The firm's concentrated thesis means its network depth in healthcare likely exceeds that of generalist peers.

The firm's fund structure is not publicly documented. India-focused growth equity firms often operate through pooled blind-pool funds with 8–10 year lifecycles, though some managers use deal-by-deal special purpose vehicles or rolling capital structures. Without public fund filings or LP disclosures, the exact legal structure remains a matter of private negotiations between the firm and its capital partners.

Public record does not confirm specific co-investment patterns or syndicate partners. In India's healthcare private equity market, co-investments are common — generalist funds frequently invite sector-specialist firms into rounds for domain expertise, and vice versa. The firm's participation in multi-investor rounds would be consistent with standard practice in the region, but no named co-investors have been disclosed in publicly available English-language reporting.